transplantation
cardiac biology
ai
mitochondrial energy production
icd
diabetes mellitus
systolic function
cox
ivc
cardiovascular disease
driveline injury
health care systems
thrombotic obstruction
etiology
ivabradine
implantable cardioverter
nfat signalling
genetic
cardiac
inflammatory stimuli
shunt
diagnosis
cardiology
irs1
cardiac cachexia
third heart sound
bundle branch morphology
100
bisphosphonate
medical
hyperinsulinemia
ventricle end
nfat
rate
peak
p70s6k
estimated
surgically
multivariable adjustment
tidal co2
tunel
rad
dysfunction
diuretic
infusions
medication
pro6-gly7
anemia
type v
hfref
adiponectin
cox proportional hazards analyses
microarray
kidney
pef
uninephrectomy
endothelial function
metabolism
cholesterol
net
vascular
clinician
ecct
correlation coefficient
surgery
auc
ventricle overload
cinahl
venous thromboembolic events
ss20
methodology
sinus rhythm
shuttle walk test
tricuspid annular
sympathetic nervous systems
kidney failure
dopamine
protein kinase a
ies
lesion
health care
immunodetection
odds ratio
inotropic effect
uptitrations
structured
chromatin structure
liver
cardiac stress
risk stratification
murine
peripheral muscle pump
sa
lean mass quantification
bolus
gastrointestinal
frailty
antagonists
lipoprotein
circulation
af
obesity
functional enrichment analysis
dna
bpm
hscrp
peak oxygen uptake
chf
physician
parasympathetic tone
resting hr
functional class
clinical practice
differential analysis
regression
nanomolar
hazard models
qrs complex
ctnt
aldosteron
ejection fraction
cpr
cardiopulmonary bypass
cardiovascular
diastolic pressure
level
.59
renal chloride channel gene
septal wall cs
hypoxia
dialysis
biventricular support
copd
pharmacologic
isoforms
noninvasive
mri
vo2 max
pharmacological
lbbb
tricuspid annular plane
systolic volume
uptitration
cpg
nbdmards
vegf expression
extracorporeal membrane
electromechanical delay
nonterminal epitopes
renal denervation
sst2
cardiac tissue
cellular
peptide
tapse
outpatients
fluid overload
longitudinal
eh
hospital
cardiac support
cardiopulmonary exercise test
pol ii
intubation
lcz696
sulfonylureas
where
cardiac arrest
progenitor cells
contemporaneous control
breathing
cardiac angiogenesis
rvads
shock
progenitor function
cytoskeleton
receptor blockers
pulmonary disease
transcriptional
bridge
gastrointestinal bleeding
doctors
hno donor
signaling
liver disease
acr
dilatation
ea
qrs duration
atrial structure
ventricular wall stress
t1/2
ss
hemodynamic disorder
epicatechin
diabetes
primary
sd
curative
diastolic filling
coronary disease
titrated
correlation
mitral flow velocity
regression models
cross talk
ef
t1 time
signal transduction cascade
reoperation
inotropic
ventricular pacing
nonsignificant
nonterminal
ventricular action potential duration
continuous flow
molecular scaffolds
coronary artery occlusion
cachexia
antiplatelet agents
chromatin hyperacetylation
cardiomyopathic
angii
renal disease
6mwt
air
echocardiographic examination
dyspnea
rs10927887
comorbidities
vad
pna
implant
secondary endpoints
multivariable cox modeling
angina
or iv
medications
histologically
ventricular tachycardia
rhythm
less
pb
systolic hf
followed
ste
diuretic response
invasively
terminal
tgf - β inhibition
symptomatic
long axis function
neprilysin
diagnosed heart failure
heart failure index
alendronate-
rehospitalization
ingenuity
prognostically
medical support
ventricular contractile reserve
mitochondrial
preoperative
expression
dying
ventricular mechanics
nf
nitrite
lvad
antibodies
cellular dysfunction
systemic
raas
myocardial tissues
hazard ratio
trastuzumab
af ablation
zsf1
cardiac magnetic resonance imaging
ecg
ch
catabolic
s1pr1s
tolvaptan
adrenomedullin
ec
rv
rna
rheumatoid arthritis
physical
vegf
irs2
titin
myxomas
myxoma
dyssynchrony
resting tension
stenotic physiology
functional enrichment
pd
pioglitazone
systolic blood pressure
prolapse
ventricular tissue
electrolytes
nps
cardiomyopathy
complicity
heart association class
qrs prolongation
t2d
tumor necrosis factor
device
stable
vascular diseases
myocyte
pvf
intubated
ventricular dilatation
nyha
ventricular diastolic function
surgeons
lipolysis
ami
multisystem disease
hospitalizations
autonomic dysbalance
heart rate reduction
cardiovascular system
general anaesthesia
acetylcholinesterase inhibition
plasma membrane
pharmaceuticals
dhand
ventricular pump function
differential
kappa coefficient
hazard ratios
ventricular filling pressure
catheterization
implanted monitoring devices
psychometric
ventricular dysfunction
potassium
myocyte depolarization
vasopressin
peak quadriceps force
tnf)α
sympathetic activity
aucs
central blood pressure
cox proportional hazards models
aac
diastolic function
diseased
cardiopulmonary
scn5a
explanted
icd shocks
mva
density
protein response
reduced ef
cgmp synthesis
na+ channel
candesartan
compliance
organ failure
hemoglobin
therapies
be
sensitivity
ra
atrial
polytetrafluoroethylene tube
defibrillator
tac
heart association
vasodilatory
muscular strength
frail
dpp-4
reticulum
diastolic murmurs
regression models stratified
endothelial growth factor
cad
leaflet resection
shunts
atrial area
xo
% confidence
ventilation
angiotensin ii
free wall cs
insulin
sinus
cfa
type 2 diabetes
sickle cell disease
phenylephrine
kappa coefficients
haplotype
hand2
enzyme inhibitors
mitochondrial function
diastolic dysfunction
ventricular pressure overload
adipokines
comanagement
cytoskeletal actin dynamics
functional capacity
sarcomere shortening
rv dysfunction
myocardial washout
dpp-4 inhibitors
catheterisation
gse9128
troponin
implantation
surgical palliation
transcription factor networks
timed up & go
preserved
myocardial infarction
gut
ras
bet
heart failure
emd
at
muscular
inotropes
idiopathic
parasympathetic neurotransmission
perk
phenotype
mrna splicing
septal
massive embolism
tachyarrhythmias
vvd
repolarization
parasympathetic function
plasma
strain
misdiagnosis
cardiac growth
mri scanner
pulsatile afterload
skeletal muscle
cell
transcription
degenerative
aldosterone receptor antagonists
sarcomere
correlate
leaflet opening
confidence intervals
arg16
endothelial cell
autonomic imbalance
micrornas
icds
pathological
phosphodiesterase-2
cardiac volume overload
followed up
anastomosis
mild heart failure
medical treatment
acute heart failure
adjuvant
mitochondrial dysfunction
paf
functional status
rm
exercise
pathophysiological
correlated
remodeling
prevalence
systemic blood pressure
glucocorticoid
acute care
ambulatory
decisions
hdl
bromodomain
asymptomatic
lv function
nyha classification
cxl-1051
neuronal stressors
preserved ejection fraction
ffm
open chest
receptor 1
apex
lesions
relative
genes
ventricular assist system
clinical
hypertension
nri
fluorescence resonance energy transfer
resynchronization
or iii
cardioprotective signaling
readmission rate
adipose tissue
vascular resistance
vegfr2
mitral regurgitation
avd
prospective
biologic
endothelial
mild hf
cgmp
%
rem
randomized control
outcomes
cardiac fibrosis
autonomic balance
ventricular assist device
transgenic
lean body mass ratio
saxagliptin
pulsatile devices
papillary muscles
cardiac index
gene expressions
inflammatory
β1ar
porcine
gluconeogenesis
mammalian
blood
nuclear factor
genomic
protocol
lad
pneumonia
pharmaceutically
intensive care unit
glu27
nurse
g
drug
myoctyes
conditions
ang ii
vasopressin receptor antagonist
rv support
nonischemic cardiomyopathies
t test
ventricular diastolic
cardiovascular events
mir-25
cyclic adenosine monophosphate
atp demand
vascular disease
pasp
hemodynamic status
fractional shortening
postmenopausal
mammalian enabled
eplerenone
change in
remodelling
fm
syndromes
sympathovagal balance
rate control
neurohormones
ie
hospital-
deficit index
co
gene expression profile
tonometric
body mass index
antihyperglycemic agents
icc values
vegf signaling pathway
anti
video edge detection
ventricular action potentials
95
total arterial compliance
clinicians
parasympathetic control
aetiologies
c termini
hospitals
metoprolol succinate
immunoreactive
proteomic
left
osteoporosis
central glycosylated region
cardiopulmonary exercise testing
left bundle branch block
multivariable
ivc occlusion
immunoprecipitation
radiological
risk
phosphorylation
na+
cardiomyocytes
myocarditis
skm
histone
hemodynamic
admissions
cri
right coronary artery
histone acetyltransferases
urban
myocardial
doxorubicin
ci=1.04
abdominal aortic constriction
was
vascular stiffness
myocardium
ischemic cerebrovascular
renal function
antagonist
alendronate
nesiritide
methotrexate
echocardiography
pro2-leu3
[
jq1
phenotypes
randomized
prognosis
implantable defibrillators
camp hydrolysis
fibrosis
ischemic cardiomyopathy
cardioprotective
volume
homozygous
ckd
systolic dysfunction
inotrope
chronic
right
pad
anticoagulants
energy
dxa
myocardial ischemia
sts
hemodynamically
standard error of measurement
cardiography
linear models
arni
beta blockers
myocardial tissue
beat
chelation
cyclic guanosine monophosphate
antagonism
skeletal muscle mass
vasodilator
biventricular pacing
outcome
cis
receptor kinase-2
body
)
readmission
randomised
mitral annulus velocity
bleeding
gdmt
serum
bhlh
legal
hhd
left bundle
reduced ejection fraction
proteins
cardiac failure
ventricular contractile function
signalling pathways
hemoglobin threshold
acs
rv function
qol
mena
kidney disease
peak oxygen consumption
cell senescence
implantable
s1pr1
genotyped
atrioventricular delay
disease
odds ratios
and salt
quality of
functional class iv
cr
lvas
blood loss
sphingosine-1-phosphate
fontan
chemotherapy
postoperative
brd4
leaflet
baseline ef
dipeptidyl peptidase-4
retrospective cohort study
hgb
extracorporeal membrane oxygenation membrane support
hh
interventricular delay
receptor antagonists
troponin t
endothelial dysfunction
progenitors
myocardial collagen
centrifugal flow pump
intravenous
ic
downregulation
myocardial extracellular matrix accumulation
contractility
multivariate analysis
sympathetic
transplant
cardioprotection
healthy
bax
chop
ventricular base
brachial
pro75-arg76
decompensated
shunting
tug
implanted cardioverter
neuro
catheter ablation
rcts
lean mass
mitral valve
histological
ventricular assist device support
aortic valve
btt
resuscitation
aldosterone antagonist
idiopathic dilated cardiomyopathy
implantable cardioverter defibrillator
epigenetic
mdc
sitagliptin
functional
stroke volume
coprimary outcome
or
transcatheter
drugs
for
patients
trichrome blue histologic
arterial elastance
lv mass
guanylate cyclase
ventricular
sarcomeric
adjusted odds
patient
cha₂ds₂vasc score
sympathetic outflow
lung congestion
myocardial fibrosis
atherosclerosis
mass spectrometric analysis
nephropathy
implanted
overload
adverse
hm
subproteomes
msec
life expectancy
gene
syndrome
infarcted
isoproterenol
ees
lv dilatation
epithelial
heart magnetic resonance imaging
polymerase ii
covariates
fibrillation
primary end point
bivp
,
posterior wall infarction
reverse remodeling
gln27
np
adenylyl cyclase
glomerular filtration rate
cellular plasticity
atrial myxoma
neurohormonal systems
0.18
rnas
pathophysiology
cabg
degs
monomeric
pacemakers
min
mitral valve tethering
diastolic
regression analyses
quality of life
follow
no
chronic heart failure
with
defibrillator device
refractory cardiogenic shock
end points
tumors
cardiovascular function
random
refractory right heart
ahf
hvad
biomarkers
antioxidant
nontrastuzumab
polymorphism
crossover study
sympathetic tone
hno
testosterone supplementation
aldactone
eds
extra corporeal membrane oxygenation
afterload
bet inhibition
systolic
subcellular
medicine
cardiac washout
revascularization
mechanical circulatory support
ci
mitral
coronary artery bypass grafting
in vitro
pathophysiologic
pressure volume relation
multiple myeloma
extracorporeal support
bat
regression modeling
salt loading
fontan failure
chromatin
bisphosphonates
physiologic processes
comorbidity
metabolic
orally
rs
exercise tolerance
insulin resistance
xo inhibition
interquartile range
heart  
p
hormonal
pathogenesis
heart
peripheral muscles
cvd
upr
propensity score
cardiac magnetic resonance
albumin
heart failure with
crf
probnp
breathing control
left heart twist
rem2
apoptosis
aortic pressure curve
esrd
transient
neurohormonal
healthy control
diastolic stiffness
rad variant
thromboembolic events
hemocompatibility
mitochondrial respiration
telemonitoring
cardiomyiopathy
lusitropic
valsartan
mrna splice variants
immunoassays
implants
complications
consultation
heart disease
cf
spironolactone
discharged
leu3-gly4
pf
medicines
intubations
invasive
infusion
skinfold thickness
dt
tnf antagonist
lcx
egfr
observational cohort studies
transfusions
carvedilol
crt capability
renal underperfusion
significance
etidronate-
stent
surgical
dilated cardiomyopathy
von willebrand factor
mitral valve plasty
ventricles
reverse
healthcare
tidal respiration
hospitalisation
brachial index
enzymes
dilated
health status
coronary artery disease
coagulability
signalling proteins
protein
diuretics
cc
referral centre
doppler
dna fragmentation
nitroxyl
cohort study
bisphophonates
pde2-mediated
peripheral artery disease
biomedical
il6
ss31
neprilysin inhibitor
perfusion
network
genotype
and
metoprolol
na+ channels
osteomedullary biopsy
citrate cycle
chordal ruptures
defibrillation
hr
vt
epidemiology
cox models
correlations
centrifugal
anthracycline
antitachycardia pacing
myocardial extracellular matrix
ref
receptors
hearts
arterial
bisoprolol
healthstar
myosin
sv
hyperlipidaemia
cluster analysis
explants
renin
randomization
confidence interval
nris
downstream signalling
biomarker
cardiorespiratory fitness
deactivation
physicians
ring
longitudinal study
correlates
cpcs
prognostic
bcl-2
enzyme inhibitor
polymorphisms
treatment
injections
systolic pressure
rvpo
sepsis
arg83gly
resistin
significant
pathobiology
tnf antagonists
prescribing
electromechanical
nurse practitioner
integrated discrimination
stenosis
obese
atp
titin hypophosphorylation
pde2
muscle
pde superfamily
epifluorescence microscopy
renal
] ; body
aortocaval fistula
renal failure
placebo
anabolic
hr reduction
ventricular assist devices
hospitalized
tachycardia
medically
compared
ethics
terminal regions
vads
adverse event profile
no synthase activation
hyponatremia
cardiovascular reserve
transmitral blood flow velocity
drs)-stratified analyses
pediatrics
lv dysfunction
ventricular ejection fractions
bets
bb
transfusion
retrospective
holosystolic murmur
systolic   heart
plasma nps
hf
dacron patch closure
uti
testosterone
gene expression
symptoms
lvh
minimal detectable change
therapy
amyloidotic pattern
hypertensive hfpef
diastolic tethering
prospective study
adrenergic
creatinine
wall thickness
peptides
nitric oxide
diagnostic tests
aldosterone
transmitral
continuous
primary outcome
autonomic
gly16
deaths
clcnka
pathological stress
biopsies
lvef
rvad
tm
nucleolin
clinic
outpatient
arrhythmia
 
saf
nicorandil
psoriasis
morbidity
serum cystatin c
raloxifene
echocardiographic
oht
health
western blot
background
aortic valve insufficiency
symptom
icu
vo
cv events
protein 4
death
crt
randomize
type
acute
telehealth
anaerobic metabolism
hazard analyses
iron homeostasis
monocytes
breast cancer
cardiac function
t1
pulmonary hypertension
prodrug
nursing
qrs
cardiotoxicity
mr
signaling pathways
cpet
discharge
pulmonary artery
eov
cohort
endothelin
diastolic filling time
midpapillary
erythropoiesis
hyperkalemia
neoplastic agent
hypertrophy
cdp
;
vena cava
immunoblotting
attrition
camp signaling
multiorgan failure
glucose
mitochondrial structure
pacemaker
systole
 
systolic hf tissue
cardiac event
quality
vo2
clinically
diastole
electrocardiographers
viscoelastic
caspase-3
postoperatively
trastuzumb
pathology
nurses
euthanization
rehabilitation
sternal
mitral valve opening
x
neurohormonal activation
percutaneous
hrqol
pcwp
significantly
aldosterone pathway
serum potassium
pyridostigmine
cytoscape
mortality
cardiac output
receptor
c57bl/6
stem cell
hemodynamic assessments
glucocorticoids
qrs morphology
ventricular structure
angiotensin
rr
petco2
in vivo
gls
transcription factors
confidence
postsystolic function
ed
myocytes
cardiomyocyte bioenergetics
hypokalemia
circumflex artery
deficit
vascular endothelial growth factor
point
failure
admission
type 2 receptor antagonist
st2
echocardiograms
emergency room
β1ars
neurohormonal stimulation
diastolic volume index
calcineurin
systolic heart
reduced
ms
hospitalisations
cpgs
transplants
protein kinase
functional class ii
dcm
exercise capacity
absorptiometry
neurohormonally
t1-mapping
hypoalbuminemia
mitral annular velocity
systolic heart failure
icc
molecular pathways
ventricle
transcriptional pause release
calreticulin
extracorporeal membrane oxygenation
left anterior
regression analysis
proteomics
cells
explant
systolic elastance
echocardiographic score
atrial pressure
camp
heart failure.(1
adverse event
vco2
lv
end point
condition
mean
circulatory support)-derived
sonographic
mi
haemodynamic
nonprescribing
ventricular ejection fraction
baseline
pulmonary arterial
glycolysis
emergency department
hospitalization
t1 mapping
coronary angiography
bioprosthetic
ventricular function
peripheral arterial disease
hypertrophic
inpatient
urinary tract infection
fpassive)-sarcomere
sternotomy
intestinal morphology
pka
infarction
ring annuloplasty
vad support
diastolic failure
avp
adverse events
myocardial dd
bottleneck
ischemic
readmissions
protein kinase r
fontan circulation
cardiovascular event
biventricular dysfunction
anaerobic threshold
ischemic events
myocardial diastolic dysfunction
3
peripheral edema
cardiac filling
diagnosed
gene control
radioenzymatic-
sodium
cxl-1020
ecgs
t cells
multivariate models
odds
anthracyclines
svr
tricuspid valve
neurohormone
neurological
intraclass correlation coefficient
life
precapillary ph
diagnostic
speckle tracking echocardiography
ventricular fibrillation
nhs
haemodynamic stress
akt
inflammation
or=1.65
hemostasis
joint
end
prospectively
{
consultations
cardiac amyloidosis
transverse aortic constriction
hfpef
etiologic
signal transduction
type 2
fes
lvet
programmed cell death
ecmo
myocardial function
palliative care
renal dysfunction
blood testing
valve plasty
primary endpoint
prescribed
ecs
pulmonary capillary wedge pressure
anticoagulation
echo
specificity
right heart failure
extubated
cs
autonomic nervous system activity
of heart
ivabradine-
respiratory quotient
tug test
ventricular filling
cv
parasympathetic activity
volume overload
circulatory assist device
clinics
pulmonary embolism
lvads
therapeutic
midregional
david
in
neoangiogenesis
myofiber shortening
ventricular cardiomyocytes
mapk
nbdmard
heart rate
exploratory factor analysis
nosignificant
diseases
tgf
allopurinol
acf
paucity
psychosocial
pulse
concentric remodeling
cardioversions
ventricularly
therapeutics
proteolysis
gata4
bmi
implantable cardioverter defibrillators
mass spectrometry
cardiologists
coronary arteries
ventricular ejection time
rgk
standard error
donors
incidence
tonometry
bnp
stroke
